Jacqueline E. Shea - Chief Operating Officer, Inovio Pharmaceuticals, Inc

As of June 11, 2021


Jacqueline E. Shea Net Worth

  • Net worth is estimated to be at least $1.62M
  • Owns at least 21,592 units of Inovio Pharmaceuticals, Inc stock
  • Sold an estimated value of $1.94M in the last 2 years at Inovio Pharmaceuticals, Inc

Jacqueline E. Shea Compensation at Inovio Pharmaceuticals, Inc in 2020

  • Earned a $430,769 salary
  • Rewarded $1,499,996 in stock value and options
  • Received a total compensation of $2,137,311

Jacqueline E. Shea Trading

  • Largest purchase of shares was 77,624 units , worth over $281K on January 29, 2021
  • Largest sale of shares was 45,049 units , worth over $541.72K on January 29, 2021
  • In total has made about 9 transactions over 2 years
  • Usually trades in March, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jacqueline E. Shea Mailing Address

  • Mailing address is C/o Inovio Pharmaceuticals, Inc. 660 W. Germantown Pike, Suite 110 Plymouth Meeting PA 19462 PA

Inovio Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. Joseph Kim, Ph.D. 2020 $694,645 $3,499,999 $ $500,032 $13,000 $4,707,676
J. Joseph Kim, Ph.D. 2019 $837,735 $638,274 $642,803 $457,222 $12,500 $2,588,534
J. Joseph Kim, Ph.D. 2018 $726,798 $1,545,687 $391,922 $407,386 $9,250 $3,081,043
Peter D. Kies 2020 $445,639 $1,499,996 $ $198,260 $10,010 $2,153,905
Peter D. Kies 2019 $523,285 $215,096 $216,712 $177,833 $10,010 $1,142,936
Peter D. Kies 2018 $449,886 $354,783 $358,612 $158,321 $10,010 $1,331,612
Laurent M. Humeau, Ph.D. 2020 $430,769 $1,499,996 $ $193,600 $13,000 $2,137,365
Laurent M. Humeau, Ph.D. 2019 $393,903 $199,398 $200,970 $165,760 $12,500 $972,531
Jacqueline E. Shea, Ph.D. 2020 $430,769 $1,499,996 $ $193,600 $12,946 $2,137,311
Jacqueline E. Shea, Ph.D. 2019 $335,000 $181,000 $465,120 $165,760 $10,154 $1,157,034
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1055726/000105572621000033/ino-2021xproxy.htm

Inovio Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 2,000 units sold on January 21, 2022 by Simon X Benito worth over $8.54K
  • In the last 16 years, insiders at Inovio Pharmaceuticals, Inc sold an estimated value of $37.6M and bought an estimated value of $11.66M
  • The most active traders are Jong Joseph Kim, Chief Executive Officer,  Peter Kies, CFO,  and David Greenhouse Austin Marxe
  • Insider trading is most common in May, with the busiest year in 2021 and 2011

INOVIO PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1